Programme

Morning Abstract and Concurrent Sessions

Basic and Translational Science - Part 2

4:45 PM – 6:00 PM Room Hall 1-2 Posters
- CH25H alleviates liver ischemia-reperfusion injury by regulating NOD2 palmitoylation-mediated membrane lipid remodeling
  
  Tao Qiu (CN) · P4-865
  
  Details
- Complement binding alone is insufficient to drive phagocytosis through liver macrophage enriched CRIg receptor
  
  Blayne Amir Sayed (CA) · P4-866
  
  Details
- Exploring the mechanism of low immunosuppression demand in polycystic kidney disease patients after kidney transplantation: The role of CD209+ macrophages
  
  Difei Ren (CN) · P4-867
  
  Details
- Spermine promotes thymic regeneration in aged mice to increase naive T cell reconstitution and restore antibody-induced transplant tolerance
  
  Gaoping Zhao (CN) · P4-868
  
  Details
- IVIG induces paradoxical activation of monocyte-derived antigen-presenting cells in immunologically stable conditions
  
  Masato Shizuku (JP) · P4-869
  
  Details
- Mechanistic Study of SLC40A1-Mediated Iron Metabolism Reprogramming in Kupffer Cells for Neutrophils Recruitment in Liver Transplant Ischemia Reperfusion Injury
  
  Peng Jiang (CN) · P4-870
  
  Details
- Different Induction Strategies in Kidney Transplantation: A Comparative Analysis of Alemtuzumab, Alemtuzumab plus Eculizumab, and Basiliximab
  
  Stanislav Shchekaturov (RU) · P4-871
  
  Details
- Study on the mechanism of targeted complement inhibitor in regulation of mouse hind limb transplantation
  
  BIAO LEI (CN) · P4-874
  
  Details
- Influence of CYP genetic polymorphism on tacrolimus pharmacokinetics in renal recipients: Evidence in kazakh population
  
  Islam Madadov (KZ) · P4-875
  
  Details
- From fixed dosing to AUC-guided monitoring: Optimizing mycophenolate mofetil therapy in kidney transplant recipients
  
  Nuria Lloberas (ES) · P4-876
  
  Details
- Attempt to minimize maintenance immunosuppressive therapy based on T and B cell epitope mismatch: Difference between PIRCHE-II and PIRCHE-T2
  
  Takaaki Kobayashi (JP) · P4-877
  
  Details
- Corticosteroids attenuate Tacrolimus-induced chronic nephrotoxicity via suppression of tubular NF-κB/STAT3 signaling: A mouse-to-human translational study
  
  Tatsuya Hoshi (JP) · P4-878
  
  Details
- Chimeric liver and immunosuppression withdrawal in long-term liver transplant recipients
  
  Wei-Chen Lee (TW) · P4-879
  
  Details
- Detection and management of Latent TB in kidney transplant candidates. A retrospective study.
  
  Armelle Villalobos (CA) · P4-883
  
  Details
- Safety and Outcomes of Kidney Transplantation Using Exceptional Distribution Increased-Risk Donors.
  
  Armelle Villalobos (CA) · P4-884
  
  Details
- Donor-derived HHV-8 causing multicentric Castleman disease with Kaposi sarcoma after kidney transplantation
  
  Camille N. Kotton (US) · P4-885
  
  Details
- PCR viral load thresholds corresponding to CMV antigenemia cutoffs in kidney transplant recipients
  
  KENTA FUTAMURA (JP) · P4-886
  
  Details
- Early detection of CMV dnaemia identifies recipients at risk for poor early outcomes after liver transplantation
  
  Kyeong Sik Kim (KR) · P4-887
  
  Details
- Prevalence of persistent infections in pre-kidney transplant patients
  
  Mónica Buonpensiere (DO) · P4-888
  
  Details
- IgM-enriched intravenous immunoglobulin as adjunctive therapy in kidney transplant recipients with severe infections: A retrospective cohort study
  
  Nikolina Basic-Jukic (HR) · P4-889
  
  Details
- Clinical and Microbiological Risk Factors Associated with Histopathological Fungal Infection in Liver Transplant Explants: A Retrospective Cohort Analysis
  
  Uta Merle (DE) · P4-890
  
  Details
- Infections and surgical site complications following kidney transplantation: Risk factors and clinical implications
  
  Valeria Ripa (US) · P4-891
  
  Details
- SGLT2 inhibitors and the risk of urinary tract infections in kidney transplant recipients: A propensity score matched multicenter cohort study
  
  YoonJU Kim (KR) · P4-892
  
  Details
- Computational fluid dynamics modeling of donor liver cooling during hypothermic perfusion: Evidence for temperature gradient-driven heterogeneous ischemic injury
  
  Bakhtiyar Kazymov (RU) · P4-895
  
  Details
- Therapeutic mild hypothermia in brain-dead donors: A systematic review and meta-analysis
  
  Grigorios Voulalas (GB) · P4-897
  
  Details
- Histone H4 lysine 12 lactylation drives METTL3 dependent N6 methyladenosine modification of PRDM15 to promote ferroptosis in renal ischemia reperfusion injury
  
  Jiale Wang (CN) · P4-899
  
  Details
- The efficacy of intraoperative dexmedetomidine on delayed graft function in patients receiving a kidney transplant: The KEYSTONE trial proposal.
  
  Jonathan Bannard-Smith (GB) · P4-900
  
  Details
- ERO1⁺ macrophage polarization drives hyperlactatemia-aggravated hepatic ischemia-reperfusion injury after liver transplantation
  
  Lin Ji (CN) · P4-901
  
  Details
- DRSAb targeting ATP1A1 inhibits ferroptosis in renal ischemia reperfusion injury by reguating ACSL4
  
  Yixuan Li (CN) · P4-902
  
  Details
- The usefulness of prebiotics-derived short-chain fatty acids in liver ischemia–reperfusion injury.
  
  Yoichiro Uchida (JP) · P4-903
  
  Details
- IDHP protects against renal ischemia-reperfusion injury through HMOX1/ferroptosis pathway
  
  Chenguang Ding (CN) · P4-905
  
  Details
- Lactylation-driven METTL3-mediated m6A modification of PCK1 aggravates tubular epithelial cell apoptosis in renal ischemia-reperfusion injury
  
  Chenguang Ding (CN) · P4-906
  
  Details
- LEA29Y pigs facilitate a local break down of remodelling processes in post-ischemic myocardial scar formation under immunosuppression
  
  Heinke Heymer (DE) · P4-911
  
  Details
- Gut Metatranscriptome Pathways Associated with Mycophenolic Acid Pharmacokinetics in Kidney Transplant Recipients
  
  Ajay Israni (US) · P4-912
  
  Details
- Computational modeling of portal vein thrombosis after liver transplantation: A coupled navier-stokes / reduced coagulation cascade approach with quantum computing perspective
  
  Boris Yaremin (RU) · P4-913
  
  Details
- Gut microbiome stability across ABO compatibility in kidney transplantation: Longitudinal fecal microbiome and targeted metabolomics profiling
  
  JIN-MYUNG KIM (KR) · P4-914
  
  Details
- Single cell analysis reveals an NK2 driven monocyte interaction axis in antibody mediated rejection after kidney transplantation
  
  JIN-MYUNG KIM (KR) · P4-915
  
  Details
- APOE promotes fibrosis in DCD kidney transplantation by regulating macrophage lipid metabolism through the TREM2-PI3K/AKT pathway
  
  Qianchao Hu (CN) · P4-916
  
  Details
- Region-Specific Mitochondrial Pathway Downregulation in BK Virus–Associated Nephropathy
  
  Soie Kwon (KR) · P4-917
  
  Details
- Methionine deficient high fat diet induces stress responsive reprogramming in hepatic ILC1 and NK cells and promotes tumor growth
  
  Yoshitaka SAEGUSA (JP) · P4-918
  
  Details
- Cytokine and cardiovascular proteomics identify circulating biomarkers of allograft rejection in heart transplantation
  
  Zeying Du (US) · P4-919
  
  Details
- Integrated evaluation of thermal stability and operational outcomes in abdominal organ transport using LifeSafe organ transport container
  
  Arif Rahman (US) · P4-920
  
  Details
- Cytokines profile in donation after cardiac death with sequential NRP and ex situ MP
  
  Daniele Pezzati (IT) · P4-921
  
  Details
- First Experience with Normothermic Machine Perfusion in Kazakhstan
  
  Jamilya Saparbay (KZ) · P4-923
  
  Details
- Surgeon perspectives and practice patterns of machine perfusion in liver transplantation in the United States
  
  Justin Steggerda (US) · P4-924
  
  Details
- Normothermic Machine Perfusion Attenuates Mitochondrial Injury in Rat Livers from Donated After Circulatory Death
  
  Lin Fan (CN) · P4-925
  
  Details
- Incorporating a Hepatic Bioreactor in Ex Vivo Lung Perfusion Enhances the Milieu of Lung Preservation
  
  Pablo Sanchez (US) · P4-926
  
  Details

Bridge2Life Corporate Breakfast Symposium on Scaling better outcomes: The role of HOPE in contemporary transplant programs

7:00 AM – 8:00 AM Room Parkside 1&2 Industry Symposium

Organized by

No lectures listed yet.

Prediction of kidney transplant outcomes

8:00 AM – 9:00 AM Room Cockle Bay 1 Abstract Session
Moderators: Tracey Ying (AU), Vikas Sridhar (CA)
- A dynamic prediction model for transplant renal artery stenosis based on donor atherosclerotic lesions at the renal artery ostium
  
  Yiling Fang (CN) · 301-1
  
  Details
- Impact of baseline isoagglutinin titer on outcomes in ABO-incompatible kidney transplantation: a French multicenter study
  
  Lionel Couzi (FR) · 301-2
  
  Details
- Prognostic significance of early donor-derived cell-free DNA elevations after kidney transplantation
  
  Didier Mandelbrot (US) · 301-3
  
  Details
- The impact of the type of post-transplant thrombotic microangiopathy on graft and patient outcomes
  
  Ekaterina Ivanova (RU) · 301-4
  
  Details
- Performance of Computable Phenotypes for Identification of Immunosuppression Related Complications in Kidney Transplant Recipients within the Patient-Centered Clinical Research Network
  
  Vikas Dharnidharka (US) · 301-5
  
  Details
- Molecular HLA matching as predictive factors for graft and patient outcomes in kidney transplantation: a systematic review
  
  Kristy Nguyen (AU) · 301-6
  
  Details
- The Canadian Highly Sensitized Patient (HSP) program: post–deceased donor kidney transplant survival comparable to national benchmarks
  
  Kyle Maru (CA) · 301-7
  
  Details
- Mediation analysis of delayed graft function and graft loss in kidney transplant recipients
  
  Dharshana Sabanayagam (AU) · 301-8
  
  Details
- Short-term PM2.5 Exposure and Hospital Readmission After Kidney Transplantation: A Nationwide Time-Stratified Case-Crossover Study
  
  Ting Lu (US) · 301-9
  
  Details

Omics in transplantation 2

8:00 AM – 9:00 AM Room Cockle Bay 2 Abstract Session
- Integrating radiomics and spatial transcriptomics for predicting hepatocellular carcinoma post-transplant recurrence and deciphering the metastatic-permissive spatial niche
  
  Zhikai Jiang (CN) · 302-1
  
  Details
- Spatial single-cell mapping of liver allograft inflammation reveals distinct immune microenvironments
  
  Timucin Taner (US) · 302-2
  
  Details
- Ccl5⁺ Macrophages Orchestrate Immunometabolic Interaction in Cardiac Allograft Rejection via Integrated Multi-Omics
  
  Quan Zhuang (CN) · 302-3
  
  Details
- Tissue-resident hematopoietic stem cells in the liver provide a functional basis for post-transplant microchimerism
  
  Allison Banuelos (US) · 302-4
  
  Details
- Temporospatial profiling reveals three-way T cell chimerism and alloreactivity in a patient receiving a second intestinal transplant
  
  Jianing Fu (US) · 302-6
  
  Details
- Comparative Analysis of Outcomes and Perfusate Proteomics from a High-Volume U.S. Center
  
  Tiffany Lim (US) · 302-7
  
  Details
- Defining the Immune-Metabolic Landscape of Aged Allografts: Insights from Metabolomic Profiling in Acute Heart Transplant Rejection
  
  Sarah Tsou (US) · 302-8
  
  Details

Mechanisms and management of AMR in kidney transplant recipients

8:00 AM – 9:00 AM Room C3.3 Abstract Session
Moderators: Wenshi Jiang (CN), Ruth Sapir-Pichhadze (CA)
- Prolonged CD38 targeting with felzartamab achieves sustained suppression of antibody-mediated rejection in kidney transplant recipients: a biomarker-guided open-label phase 2 extension
  
  Katharina Mayer (AT) · 303-1
  
  Details
- Unbiased and Spatial Proteomics of Kidney Allograft Biopsies: Terminal Complement Proteins Dominate Chronic Active Antibody Mediated Rejection
  
  Maya Allen (CA) · 303-2
  
  Details
- HLA Eplet-based risk stratification for DSA and ABMR after kidney transplantation with validation of immunogenicity and immunoreactivity
  
  Zhou Guxiang (CN) · 303-3
  
  Details
- Tissue effector signatures define distinct mechanistic phenotypes of microvascular inflammation and predict kidney allograft outcomes beyond DSA and C4d
  
  Alev Ok Atılgan (TR) · 303-4
  
  Details
- Novel IgG-Degrading Enzyme Therapy for the Desensitization in Highly HLA-sensitized Kidney Transplant Recipients: A Phase 2 Study
  
  Yongbo Wang (CN) · 303-5
  
  Details
- Characteristics of non-HLA antibodies in patients after kidney transplantation and their association with renal allograft pathological status
  
  Meihe LI (CN) · 303-6
  
  Details
- Extracorporeal photopheresis for antibody-mediated rejection in kidney transplant recipients at high risk of infection: A case series
  
  Nikolina Basic-Jukic (HR) · 303-7
  
  Details
- Outcomes After Early (≤30 Days post-transplant) Antibody-Mediated Rejection in Kidney Transplantation: A Multicenter Study in the Eculizumab Era
  
  Jose Arriola-Montenegro (US) · 303-8
  
  Details

Immunoregulation: Tolerance versus rejection 1

8:00 AM – 9:00 AM Room C3.4-C3.5 Abstract Session
Moderator: Alexandra Sharland (AU)
- Microplastic Exposure Accelerates Graft Loss in a Murine Chronic Cardiac Allograft Rejection Model
  
  Quan Zhuang (CN) · 304-1
  
  Details
- Donor γδ T cells promote blood chimerism while recipient γδ T cells contribute to graft rejection after human intestinal transplantation
  
  Bing Chen (CN) · 304-2
  
  Details
- CD300a Regulates T Cell Function to Promote Allogeneic Cardiac Graft Survival
  
  Helong Dai (CN) · 304-3
  
  Details
- Single-cell multi-omics characterization of rejection in transplanted kidneys reveals key cell types and a regulator of chronic rejection
  
  Bingxuan Zheng (CN) · 304-4
  
  Details
- Leucine attenuates allograft rejection by reversing memory-like NK cell responses via subset redistribution
  
  Jifu Ge (CN) · 304-5
  
  Details
- Longitudinal dd-cfDNA Dynamics Enable Early Detection of Acute Rejection in Pediatric Liver Transplant Recipients
  
  Agostina Arrigone (AR) · 304-6
  
  Details
- Chronic lung allograft dysfunction phenotype is associated with recipient KIR genotypes
  
  Samuel Robinson (AU) · 304-7
  
  Details

Emerging challenges in transplantation: Allocation, risk prediction, and long-term outcomes

8:00 AM – 9:00 AM Room C3.6 Abstract Session
Moderators: Lachlan McMichael (AU), Ross Francis (AU)
- The rate of glomerulosclerosis as an appropriate criterion for allocation of marginal kidneys into single or dual kidney transplantation
  
  JiaSheng Xie (CN) · 305-1
  
  Details
- Body-composition abnormalities and post-transplant prognosis in hepatocellular carcinoma liver transplantation: a multi-task clinical surrogate model
  
  Jinyan Chen (CN) · 305-2
  
  Details
- Impact of prior kasai portoenterostomy on liver transplantation outcomes in children with biliary atresia: a single-center retrospective cohort study
  
  Wanglong Xiao (CN) · 305-3
  
  Details
- Initial kidney graft function and its association with short- and long-term graft outcomes: a paired kidney analysis
  
  Wai Lim (AU) · 305-4
  
  Details
- Development of a Machine Learning Model to Predict 90-Day Mortality Risk After Deceased-Donor Kidney Transplantation
  
  Sergio Salcedo Herrera (CO) · 305-5
  
  Details
- Liver transplantation disparties by ABO blood type in the machine perfusion era
  
  Elizabeth Swanson (US) · 305-6
  
  Details

Delivering value in liver transplantation: Innovation, resources, and the future of care

8:00 AM – 9:00 AM Room C4.1 Concurrent
Moderator: Gabriel E. Gondolesi (US)
- Implementing change and managing resources: Can we do both?
  
  Alfred Kow (SG)
- Defining value in liver transplantation: Focusing on what matters
  
  Julie Heimbach (US)
- Telemedicine and remote monitoring: the potential of digital health tools to optimise patient care
  
  Brooke Huuskes (AU)

Long-term outcomes and risk stratification after liver transplantation

8:00 AM – 9:00 AM Room C4.5 Abstract Session
Moderators: Simone I. Strasser (AU), Oscar Cesar Imventarza (AR)
- Saroglitazar improves post-liver transplant metabolic associated steatotic liver disease- A randomized controlled trial- interim analysis
  
  Dinesh Jothimani (IN) · 309-1
  
  Details
- Harnessing the estrogen-PARP axis: A key to enhancing liver graft survival and combating fibrosis
  
  Binnaz Handan Ozdemir (TR) · 309-2
  
  Details
- Early Post-Transplant Recipient-Derived Cell-Free DNA Predicts One-Year Graft Survival in Liver Transplant Recipients
  
  Eun-Ki Min (KR) · 309-3
  
  Details
- 25 years of pregnancy outcomes after liver transplantation
  
  Lisa A. Coscia (US) · 309-4
  
  Details
- Temporal changes in graft failure over three decades of liver transplantation: Insights from ultra-long-term outcomes with well-maintained follow-up at a single center
  
  Masaaki Hirata (JP) · 309-5
  
  Details
- 3D muscle-omics maps muscle-specific vulnerability and prognostic phenotypes in liver transplantation for hepatocellular carcinoma
  
  Di Lu (CN) · 309-6
  
  Details
- Post-transplant MASLD does not adversely affect long-term survival or cardiometabolic outcomes following liver transplantation
  
  Ki Sang Jung (KR) · 309-7
  
  Details
- Liver Transplantation After TARE Downstaging in Advanced Hepatocellular Carcinoma: A Single-Center Experience
  
  Dahyun Jung (KR) · 309-8
  
  Details
- A 25-year experience of a “free of cost” dedicated living donor clinic in a low-middle-income countries. An insight into impediments to compliance in regular yearly follow-up and their impact on long-term outcomes
  
  Mirza Zafar (PK) · 309-9
  
  Details

Expanding transplant access: Innovations in training, simulation, and global collaboration

8:00 AM – 9:00 AM Room C4.6 Abstract Session
Moderators: Jen Li (AU), Marti Manyalich Vidal (ES)
- World’s First Heart to Heart Exchange: Connecting Children in Canada and South Africa Through Organs, Habits and Kindness
  
  Peggy John (CA) · 310-1
  
  Details
- World’s First Heart to Heart Exchange: Connecting Children in Canada and South Africa Through Organs, Habits and Kindness
  
  David Thomson (ZA)
- Barriers to Kidney Transplantation Among Dialysis Patients in a Low-Middle Income Country: A Large Patient-Reported Survey
  
  Ruchir Dave (IN) · 310-2
  
  Details
- MNGIE: Largest single-center experience of a comprehensive multidisciplinary clinic and diverse therapeutic methodologies
  
  Ehab Abufarhaneh (CA) · 310-3
  
  Details
- SimU-Skin: A 4D Tactile Simulation Platform to Improve Patient Recognition of Sentinel Skin Flap Changes Following Solid Organ Transplantation
  
  Omar Quidwai (IE) · 310-4
  
  Details
- Global kidney transplant simulation (Global-KiTSi) model: Feasibility of a low cost LMIC scalable modular kidney transplant surgery simulation platform using three dimensional printed negative moulds and silicone casting.
  
  Bishow Bekhyat Karki (GB) · 310-5
  
  Details
- Simulation based surgical skills training in liver transplantation: A scoping review of low-cost, high fidelity liver transplant simulation models in resource limited settings.
  
  Bishow Bekhyat Karki (GB) · 310-6
  
  Details
- Fellowship training and the learning curve in living donor kidney transplantation in a low-resource setting: early experience from Rwanda
  
  Alexandre NYIRIMODOKA (RW) · 310-7
  
  Details
- Strengthening organ donation systems through workforce capacity building: Implementation evaluation of the essential skills in organ donation training program
  
  Amal AlFar (AE) · 310-8
  
  Details

Optimizing pancreas and islet transplantation: From donor selection and graft preservation to functional outcomes

8:00 AM – 9:00 AM Room C4.7 Abstract Session
Moderators: John Kanellis (AU), Raja Kandaswamy (US)
- Membrane-anchored ROS scavenger protects pancreatic islets from hypoxic injury by preserving surface thiol homeostasis
  
  Jianmin Wu (CN) · 311-1
  
  Details
- Post-Transplant Diabetes in SPK
  
  Lucas Garcias (AR) · 311-2
  
  Details
- Challenging the marginal label: Pediatric donors in simultaneous pancreas–kidney transplantation
  
  Belmin B J Winston Gysley (IN) · 311-3
  
  Details
- Expanding Candidacy in SPK Transplantation: Impact of Age, BMI, C-Peptide, and Insulin Requirement on Recipient Outcomes
  
  Elif Kortan (US) · 311-4
  
  Details
- Biophysical profiling of human pancreatic organoids identifies mass mensity as a size-independent metric of maturation and function
  
  Giuseppe Pettinato (US) · 311-5
  
  Details
- Temporal trends in surgical morbidity and outcomes following Simultaneous Pancreas Kidney Transplantation: A 10 year single centre experience
  
  Sai Praneeth Reddy Perugu (IN) · 311-6
  
  Details
- Refining donor selection to expand the pancreatic islet donor pool: a retrospective cohort study
  
  Heyang Wen (AU) · 311-7
  
  Details
- Allogeneic islet transplantation for diabetic patient post-kidney transplant diabetes in 4 cases
  
  Yang Li (CN) · 311-8
  
  Details

Viral infections in transplantation

8:00 AM – 9:00 AM Room C4.8 Abstract Session
Moderators: Monica Slavin (AU), Bradley Gardiner (AU)
- Mapping the BK polyomavirus MHC class I immunopeptidome to advance antiviral immune target discovery in kidney transplants
  
  Tirath Dwivedi (AU) · 312-1
  
  Details
- Unsupervised Machine Learning Reveals Early BKPyV DNAemia Trajectories That Improve the Prediction of Kidney Allograft Outcomes
  
  Gang Huang (CN) · 312-2
  
  Details
- Breakthrough CMV DNAemia in solid organ recipients on primary valganciclovir prophylaxis
  
  Sara Belga (CA) · 312-3
  
  Details
- Cytomegalovirus DNAemia clearance with maribavir in solid organ transplant recipients with symptomatic versus asymptomatic infection: a post hoc analysis of phase 2 and 3 trials
  
  Deepali Kumar (CA) · 312-4
  
  Details
- When CMV donor/recipient risk is not one-size-fits-all: Demographic and socioeconomic modification of CMV-associated mortality after heart transplantation
  
  Maheen Abidi (US) · 312-5
  
  Details
- Extended antiviral prophylaxis mitigates impact of cytomegalovirus infection in seronegative lung transplant recipients
  
  Manushika Watagodakumbura (AU) · 312-6
  
  Details
- Early Initiation of Letermovir Prophylaxis Prevents Cytomegalovirus Infection After Liver Transplantation: A Prospective Single-Center Study
  
  Katsunori Sakamoto (JP) · 312-7
  
  Details
- CMV specific cell mediated immunity profile in Indian kidney transplant recipients
  
  Ramanand Sivaprasad (IN) · 312-8
  
  Details
- Utilization, Prevention, and Outcomes of Kidney Transplantation from HBsAg(+) Donors to HBsAg(-) Recipients: A Nationwide Survey of 74 Centers in Mainland China
  
  YING SU (CN) · 312-9
  
  Details

Novel immunosuppression

8:00 AM – 9:00 AM Room C4.9 Abstract Session
Moderators: DongJin Joo (KR), Marcelo Cantarovich (CA)
- Phase 2 BESTOW trial and the BESTOW EXTENSION: Evaluating the long-term safety and efficacy of tegoprubart in preventing kidney transplant rejection
  
  Andrew B. Adams (US) · 313-1
  
  Details
- CCL22-engineered MSCs modulate immune crosstalk to shape an immunosuppressive microenvironment for graft protection
  
  Yanan Li (CN) · 313-2
  
  Details
- Efficacy and safety of everolimus added to Tacrolimus/Mycophenolate/Prednisone in HLA-sensitized kidney transplant recipients: A randomized controled trial.
  
  Elias David-Neto (BR) · 313-3
  
  Details
- Targeted Elimination of ABO-Specific B Cells via Bispecific T-Cell-Engaging Antibody Conjugates for ABO-Incompatible Kidney Transplantation
  
  Joon Young Jang (KR) · 313-4
  
  Details
- CCR10 Defines a Potent Regulatory T Cell Subset Essential for Kidney Transplant Tolerance through Enhanced Foxp3 Lineage Stability
  
  Siyue Chen (CN) · 313-5
  
  Details
- Comparative effectiveness of thymoglobulin versus basiliximab for induction immunosuppression in older kidney transplant recipients: A target trial emulation
  
  Katharine Krupp (US) · 313-6
  
  Details
- Bioequivalence of generic immunosuppressants in kidney transplants
  
  Anders Asberg (NO) · 313-7
  
  Details

Pediatric treatments on the Horizon

8:00 AM – 9:00 AM Room C4.10 Concurrent
Moderators: Katherine E. Twombley (US), Matthew Sypek (AU)
- Partial heart transplant in children
  
  Taufiek Konrad Rajab (US)
- The micorbiome and transplantation
  
  Maria-Luisa Alegre (US)
- Regulatory cell therapy for solid organ transplantation
  
  Fadi Issa (GB)

Bridging gaps in transplantation: Equity, access, and unmet needs worldwide

8:00 AM – 9:00 AM Room C4.11 Abstract Session
Moderators: Riadh Fadhil (QA), Anantharaman Vathsala (SG)
- Estimating the scale of unmet solid organ transplantation need in India: a demographic scenario analysis to 2040
  
  SAURABH PURI (IN) · 315-1
  
  Details
- Financial sustainability of Transplant Programs in low middle-income countries. A snapshot of models providing “free of cost” transplant services.
  
  Mirza Zafar (PK) · 315-2
  
  Details
- Qualitative methodologies exploring pregnancy care for First Nations women with kidney transplantation: An Aboriginal kidney care together improving outcomes now (AKction2) co-designed study
  
  Nishanta Tangirala (AU) · 315-3
  
  Details
- “I won’t offer a kidney that I don’t think they should accept”: Nephrologists’ perspectives on patient involvement in declined deceased donor kidney transplant offers
  
  Alison Weightman (AU) · 315-4
  
  Details
- The economics of kidney replacement therapy in Tanzania: a generalizable, state-transition model for policy-driven cost-effectiveness analyses
  
  Alan Zambeli-Ljepović (US) · 315-5
  
  Details
- A Time-to-Equivalent Risk (TiTER) for decision-making in deceased donor kidney transplant candidates
  
  Jin Hyeog Lee (KR) · 315-6
  
  Details
- Multidimensional Analysis of Barriers to Organ Donation and Transplantation Development in Asia: A Mixed-Methods Study Based on Questionnaire Surveys and Expert Consensus
  
  Xiangxiang He (CN) · 315-7
  
  Details
- Sex Disparities in Transplant Waitlisting- Differences by Race, Ethnicity, and Age
  
  Mara McAdams DeMarco (US) · 315-8
  
  Details
- Impact of the MELD-based allocation system on waitlist mortality and transplant rates in Japan: A single-center study
  
  Ryoichi Goto (JP) · 315-9
  
  Details
- Improving organ donation in medicolegal cases a retrospective review from the UAE national center for organ donation and transplant from 2023 to 2026
  
  Fatima Aljaberi (AE) · 315-10
  
  Details

TTS Plenary's Plenary

TTS President's Plenary

9:15 AM – 10:30 AM Room Darling Harbour Plenary Session
- Beyond technology: Building a collaborative societal ecosystem for transplantation (Reflections from China's transplant reform)
  
  Haibo Wang (CN)
- Presidential address
  
  John J. Fung (US)

Coffee Break / Exhibits and Poster Viewing

Coffee Break

10:30 AM – 11:00 AM Room Hall 1-2 Coffee Break

No lectures listed yet.

Abstract and Concurrent Sessions

Donor risk and recipient outcomes in kidney transplantation

11:00 AM – 12:00 PM Room Cockle Bay 1 Abstract Session
Moderator: Angela Webster (AU)
- The Impact of The Modified Kidney Donor Profile Index on The Non-use of Kidneys from Donors with Hepatitis C
  
  Tarek Alhamad (US) · 330-1
  
  Details
- Does pre-donation cardiac arrest affect post-transplant outcomes in kidney transplantation: a UK NHSBT Registry Data Analysis
  
  Zaid Al-Amiedy (GB) · 330-2
  
  Details
- 1-year outcomes of kidney transplantation from donation after circulatory death using normothermic regional perfusion (NRP) – a single-center experience
  
  Alex Zendel (US) · 330-3
  
  Details
- Long-term outcomes of kidneys from donors following medical assistance in dying
  
  François Méthot (CA) · 330-4
  
  Details
- Donor factors associated with poor early graft outcomes – a retrospective observational study over two decades from the ANZDATA registry
  
  Gina Davis (AU) · 330-5
  
  Details
- Imaging-based nephron mass estimation using BSA-normalized CT renal volume predicts early remnant kidney dysfunction in living kidney donors
  
  Manish Malik (IN) · 330-6
  
  Details
- Eplet mismatch does not predict outcomes in living related kidney transplantation as induction therapy overrides molecular risk
  
  KAPIL VIJAYKUMAR GOTHWAL (IN) · 330-7
  
  Details
- Association between donor albuminuria and the risk of graft failure in living-donor kidney transplantation: A retrospective cohort study
  
  Chengze Liang (CN) · 330-8
  
  Details
- Quality of Life After Living-Related Kidney Donation in an Indigenous High Volume Transplant Programme in Nigeria: Determinants from a WHOQOL-BREF Analysis.
  
  Hyginus Ekwuazi (NG) · 330-10
  
  Details

Immunosuppression: Experimental and clinical

11:00 AM – 12:00 PM Room Cockle Bay 2 Abstract Session
- A Novel Biomarker for Immunosuppression Minimization
  
  Marilia Cascalho (US) · 331-1
  
  Details
- Beyond tacrolimus levels: NFAT-Residual Gene Expression as a Renal Transplant Rejection and Infection Predictor
  
  Ritika . (IN) · 331-2
  
  Details
- Pre‑IND Evaluation of Orthotopic Cardiac Xenotransplantation Using Ten‑Gene‑Edited Porcine Donor Hearts with a Clinically Relevant Immunosuppressive Regimen in Non‑Human Primates
  
  Avneesh Singh (US) · 331-3
  
  Details
- Engineering tacrolimus-resistant A2-CAR Tregs for use in solid organ transplantation
  
  Robert Wright (CA) · 331-4
  
  Details
- Donor carbon monoxide treatment alone prolongs pulmonary allograft survival and suppresses brain death-induced graft inflammation in CLAWN miniature swine
  
  Hisashi Sahara (JP) · 331-5
  
  Details
- Lung allograft VCAM-1: a ligand for graft targeting of nanoparticles post-lung transplantation
  
  Logan Langerude (US) · 331-6
  
  Details

Immunologic risk, donor factors and predictive modelling of kidney transplant outcomes

11:00 AM – 12:00 PM Room C3.3 Abstract Session
Moderator: Alessandra Orsillo (AU)
- Three-year incidence and phenotype of de novo donor-specific antibodies and complement-binding subsets after kidney transplantation: results from the DOSAKOM phase IV cohort
  
  Jun Bae Bang (KR) · 332-1
  
  Details
- Homozygosity at HLA-A, especially the A24 antigen, is an independent risk factor for higher PRA post-transplant and reduced opportunities of subsequent transplant
  
  Anne Taverniti (AU) · 332-2
  
  Details
- Impact of donor hypertension on kidney transplant outcomes - An analysis of the Collaborative Transplant Study (CTS)
  
  Christian Unterrainer (DE) · 332-3
  
  Details
- Temporal decay in the performance of Cox proportional hazards models for deceased-donor kidney graft survival
  
  Aniket Sinha (AU) · 332-4
  
  Details
- Development of a multidimensional machine learning model integrating clinical, perfusion, donor scoring and pathology data for predicting delayed graft function in deceased donor kidney transplantation
  
  Guozhen Chen (CN) · 332-5
  
  Details
- Serum induced trained immunity responses are associated with clinical outcomes after pediatric kidney transplantation
  
  Longshan Liu (CN) · 332-6
  
  Details
- Gene Spark: Genetic Survey of Paediatric Kidney Transplant Patients
  
  Ananya Deshpande (AU) · 332-7
  
  Details
- Longitudinal Graft Function Trajectories in Crossmatch-Positive Living Kidney Transplantation
  
  Toshihito Hirai (JP) · 332-8
  
  Details
- Machine learning prediction of 30-day bleeding complications in desensitized kidney transplant recipients
  
  Ahram Han (KR) · 332-9
  
  Details
- A systematic method to evaluate kidney allocation algorithms in Australia
  
  Owen Ng (AU) · 332-10
  
  Details

Immunoregulation: Cell signalling 1

11:00 AM – 12:00 PM Room C3.4-C3.5 Abstract Session
- Targeting VDR-sirt5-PHB2-mediated mitophagy to reverse vascular endMT and prevent chronic renal allograft dysfunction
  
  Qinghuan Shen (CN) · 333-1
  
  Details
- Phosphodiesterase-5/5-HT2B antagonism regulates fibrotic potential of renal allograft fibroblasts isolated from renal allograft rejection patients by targeting TGF-βeta1-Src-ERK1/2-STAT3 Pathway
  
  Saurabh Chaturvedi (IN) · 333-2
  
  Details
- G-MDSC derived LETS1 promotes mesenchymal stem cell differentiation into myofibroblasts via targeting TGF Beta Receptor I in renal fibrosis
  
  Xinhao Niu (CN) · 333-3
  
  Details
- A mechanistic model to investigate Non-HLA Mismatches in LIMS1-GCC2.
  
  Madhav Menon (US) · 333-5
  
  Details
- Targeting Innate Allorecognition Via CD47-Sirpa Prolongs Cardiac Allograft Survival In Presensitized Recipients
  
  Martin Oberbarnscheidt (US) · 333-6
  
  Details
- The transcription factor Bhlhe40 promotes alloreactive CD8+ T cell differentiation from TCF-1+ effector progenitors in Graft-vs-Host Disease
  
  Kate Gartlan (AU) · 333-7
  
  Details

Multi-omics and immune profiling in transplantation: Kidney-focused advances with cross-organ insights

11:00 AM – 12:00 PM Room C3.6 Abstract Session
- Deep Characterization of the Kidney Transplant Immune Microenvironment via Multimodal Deep Learning and Single-Cell Spatial Transcriptomics
  
  Jiaheng Wu (CN) · 334-1
  
  Details
- Distinguishing Pathogenic Alloimmunity from Immunological Noise in DSA-Negative Kidney Rejection: A Multimodal Framework Validated in GSTT1-Null Recipients
  
  Xiantian Pan (CN) · 334-2
  
  Details
- Spatial multi-omics dissection of tertiary lymphoid structure maturation and composition predicts post-transplant outcomes and pre-operative immunotherapy response in hepatocellular carcinoma
  
  Zhikai Jiang (CN) · 334-3
  
  Details
- A systematic review of reported use of genetic testing in kidney transplantation
  
  Sadia Jahan (AU) · 334-4
  
  Details
- Integration of a pre-transplant 15-protein serum proteomic signature predicts recurrence after liver transplantation for HCC: A multicenter KOTRY registry study
  
  Suk Kyun Hong (KR) · 334-5
  
  Details
- Potential Value of Targeting the TIM-4/PS Signaling Pathway in Promoting Immune Tolerance in Kidney Transplantation
  
  Qiang Fu (CN) · 334-7
  
  Details
- Genome-wide investigation of variants associated with kidney allograft survival
  
  Angelita Liang (AU) · 334-8
  
  Details

Transplant outcomes, bridging strategies, and global advances in liver transplantation

11:00 AM – 12:00 PM Room C4.1 Abstract Session
- HLA-DQ molecular mismatch-derived risk score predicts acute rejection and development of de novo donor-specific antibodies in pediatric liver transplantation
  
  Agostina Arrigone (AR) · 335-1
  
  Details
- Liver transplantation after neoadjuvant TACE in HCC: impact of cone-beam CT on bridging and downstaging strategies assessed by the Metroticket 2.0 model
  
  Sergey Astapovich (RU) · 335-2
  
  Details
- Post-Transplant Lymphoproliferative Disorder in Paediatric Liver Transplantation: A National Centre Experience from New Zealand
  
  Yae Jhee Lee (NZ) · 335-3
  
  Details
- Outcomes of liver transplantation for metabolic dysfunction–associated steatotic liver disease in the United States
  
  REZA SAIDI (US) · 335-4
  
  Details
- Perioperative glucose alterations and liver transplantation outcomes: A Mongolian cohort study
  
  Sarnai Erdene (MN) · 335-5
  
  Details
- The role of international collaboration in developing transplant programs: A success story from TTS-ILTS paired transplant centers program from the Paired Program
  
  Sergelen Orgoi (MN) · 335-6
  
  Details
- Establishing a protocol for liver transplantation in unresectable colorectal liver metastases: Preliminary results of an Australian clinical trial
  
  Arsalan Bakhtiar (AU) · 335-8
  
  Details
- Optimal frequency of high-flow hemodiafiltration as a bridging therapy to liver transplantation in patients with acute liver failure in Japan.
  
  Kosei Nakamura (JP) · 335-9
  
  Details
- Efficacy of transarterial radioembolization versus transarterial chemoembolization as bridging therapy to liver transplantation for patients with hepatocellular carcinoma
  
  Arpit Amin (US) · 335-10
  
  Details
- Liver transplantation outcomes in patients with secondary biliary cirrhosis following bile duct injury
  
  Eduardo Massabki (BR) · 335-11
  
  Details

Vascularized composite allotransplantation: Expanding frontiers in function, immunity, and clinical translation

11:00 AM – 12:00 PM Room C4.2 Abstract Session
- Defining long-term functional recovery in face transplantation
  
  Bruce Gelb (US) · 336-1
  
  Details
- 3-year longitudinal outcomes after the world’s first human whole eye transplant
  
  Bruce Gelb (US) · 336-2
  
  Details
- Human limb preservation using oxygenated machine perfusion with hemoglobin-based oxygen carriers modulates hypoxia and immune injury pathways
  
  Varun Kopparthy (US) · 336-3
  
  Details
- Vascular Composite Allograft Transplantation – A Single Center Experience From India
  
  Shruti Tapiawala (IN) · 336-4
  
  Details
- Emerging divides in attitudes towards uterus transplantation among health professionals in Australia and New Zealand
  
  Hayley Mallinder (AU) · 336-5
  
  Details
- Psychological and emotional profiles of Australian uterine transplant potential recipients: a comparison with international trials
  
  Tamika Baker (AU) · 336-6
  
  Details
- A decade of structural inequity in U.S. vascularized composite allotransplantation - A National OPTN Registry Analysis (1998–2024)
  
  Girish Mour (US) · 336-7
  
  Details
- NASEM-Guided CONSORT Consensus Recommendations and Standards for Face and Hand Vascularized Composite Allotransplantation: Establishing a Multicenter Clinical Trial Framework
  
  VIJAY GORANTLA (US) · 336-8
  
  Details

The journey to clinical xenotransplantation

11:00 AM – 12:00 PM Room C4.4 Concurrent
Moderator: Evelyn Salvaris (AU)
- Development of the gene edited pigs to get us to the clinic
  
  Peter Cowan (AU)
- Avoiding dysregulation of the complement and coagulation-anticoagulation systems?
  
  Jo Tector (US)
- The road to regulatory approval for clinical transplantation
  
  Muhammad Mohiuddin (US)

Expanding living donor liver transplantation: Emerging evidence and clinical advances

11:00 AM – 12:00 PM Room C4.5 Abstract Session
Moderator: Kwang Woong Lee (KR)
- Liver transplantation from donation after circulatory death in the United States: Elderly donors emerge as a critical resource
  
  Allan Massie (US) · 338-1
  
  Details
- How Can We Ensure Donor Safety with Less than 30% of Residual Volume?
  
  JOODONG KIM (KR) · 338-2
  
  Details
- Quality of Life After Robotic Living Donor Hepatectomy: A One-Year Prospective Analysis of Donor and Recipient Determinants
  
  Dieter Broering (SA) · 338-3
  
  Details
- A comparison of total intravenous and volatile anesthesia in living donor hepatectomy: a global prospective cohort study from the International Living Donor Liver Transplant Registry (LDLTregistry.org)
  
  The International Living Donor Liver Transplant Registry Collaborative (CH) · 338-4
  
  Details
- Accuracy of MRI-PDFF and FibroScan CAP for Assessing Steatosis in Living Liver Donors: A Multivariate Analysis with Weight Stability Compensation
  
  Eunjin Lee (KR) · 338-5
  
  Details
- Laparoscopic Donor Left vs. Right Hepatectomy: A Propensity Score-Matched Analysis of Donor Safety and Outcomes
  
  Eunjin Lee (KR) · 338-6
  
  Details
- Urgent liver transplantation for acute-on-chronic liver failure in national data: Impact of dynamic MELD change and donor type on survival
  
  Jongman Kim (KR) · 338-7
  
  Details
- Family perspectives on deceased organ donation: a meta-synthesis of qualitative studies on post-donation experiences and attitudes
  
  Qingqing Zhou (CN) · 338-8
  
  Details

Lung transplantation outcomes and allograft dysfunction: From mechanisms to clinical prevention strategies

11:00 AM – 12:00 PM Room C4.6 Abstract Session
Moderators: Gregory I. Snell (AU), Jyotika Prasad (AU)
- Clinical, histological and tissue proteomic features of decline after idiopathic acute lung allograft dysfunction
  
  Pamela Karas (AU) · 339-1
  
  Details
- Longitudinal immunophenotyping identifies early postoperative CD8-positive PD-1-positive T cells as an independent predictor of 1-year mortality after lung transplantation
  
  Tianyi Yang (CN) · 339-2
  
  Details
- Predicting acute kidney injury following lung transplantation: development and internal validation of perioperative prediction models
  
  Shogo Trevena (AU) · 339-3
  
  Details
- Family Experiences and Ethical Acceptability of Lung uDCD Authorization in an Opt-In System
  
  Jingzhi Xu (US) · 339-4
  
  Details
- Donor Lung Microbiome and Metabolic Signatures Predict Primary Graft Dysfunction After Lung Transplantation
  
  Guodong Wu (CN) · 339-5
  
  Details
- Randomized controlled trial comparing immediate versus extended-release tacrolimus in lung transplant recipients: the REVOLUTION trial
  
  Juul Daamen (NL) · 339-6
  
  Details
- Excellent Long-Term Outcomes in Paediatric Lung Transplantation Within a Centralised, Co-located Adult Program
  
  Miranda Paraskeva (AU) · 339-7
  
  Details
- Lung Allograft Injury Improves After Gastroesophageal Reflux Surgery According To Donor-derived Cell-free DNA
  
  Cesar Escrig (CH) · 339-8
  
  Details
- PRODON-AR: prone positioning in potential organ donors. Multicentric randomized clinical trial
  
  pablo centeno (AR) · 339-10
  
  Details

Psychosocial, communication and educational aspects of donation and transplantation

11:00 AM – 12:00 PM Room C4.7 Abstract Session
Moderators: Estephan Arredondo (ES), Bronwyn Levvey (AU)
- You don’t know what you don’t know: Developing video-based educational resources for prospective kidney transplant recipients
  
  Darren Manden (NZ) · 340-1
  
  Details
- Exploring lived experiences of kidney graft loss through narrative podcasting
  
  Anita Slominska (CA) · 340-2
  
  Details
- Barriers to effective communication about kidney graft failure: findings to guide intervention development
  
  Anita Slominska (CA) · 340-3
  
  Details
- “I’ve got no organs that are usable”: Indigenous perspectives on gifting organs following assisted death, New Zealand
  
  Tess Moeke-Maxwell (NZ) · 340-4
  
  Details
- 'Recognizing how much the kidney transplant would hold me back': A qualitative explorative study and a digital storytelling project with young adult kidney transplant recipients
  
  Chloe Wong-Mersereau (CA) · 340-5
  
  Details
- Posttraumatic Distress Symptoms in Patients on Mechanical Circulatory Support
  
  Christiane Kugler (DE) · 340-6
  
  Details
- Psychological resilience and post-kidney transplant psychosocial outcomes
  
  Kathleen Gaudio (CA) · 340-7
  
  Details
- The role of community in the well-being of living kidney donors
  
  Kathleen Gaudio (CA) · 340-8
  
  Details

Global Transplantation: The GODT Report Analyzes Activities Around the World

11:00 AM – 12:00 PM Room C4.8 Concurrent
Moderators: John J. Fung (US), Nadey Hakim (GB)
- Global observatory on donation and transplantation (GODT)
  
  Beatriz Domínguez-Gil (ES)
- Global donation and transplantation activities. An assessment of 2024 GODT data
  
  Friederike Martin (DE)
- Panelists
  
  Stefan Tullius (US)
- Panelist
  
  Dimitri A. Raptis (SA)
- Panelist
  
  David Thomson (ZA)

Optimizing and utilizing old organ donors

11:00 AM – 12:00 PM Room C4.9 Concurrent
Moderator: Helen Opdam (AU)
- Setting the stage: Older organs - clinical need, ethical and economic considerations
  
  Krista Lentine (US)
- Objective quality criteria of old organs
  
  Varvara Kirchner (US)
- Old organs and ex vivo treatment
  
  Jasper Iske (DE)

Pediatric liver

11:00 AM – 12:00 PM Room C4.10 Abstract Session
Moderators: Helen Evans (NZ), Michael Stormon (AU)
- Hepatocyte circFADS2 modulates TCMR in pediatric liver transplantation
  
  Qi Pan (CN) · 343-1
  
  Details
- HOPE improves outcomes of ex situ split liver grafts in pediatric liver transplantation
  
  Javier Serradilla (ES) · 343-2
  
  Details
- Incidence of cognitive dysfunction in children after liver transplantation: a systematic review and meta-analysis
  
  Qingqing Zhou (CN) · 343-3
  
  Details
- Liver transplantation for gestational alloimmune liver disease outcomes analysis from retrospective cohort and national case series
  
  Shreya Tamma (US) · 343-4
  
  Details
- Infant versus paediatric liver transplantation: technical and survival outcomes in a single-centre cohort study
  
  Yang Yang Lee (SG) · 343-5
  
  Details
- The Survival Benefit of Pediatric Liver Transplantation
  
  Ali Abbasi (US) · 343-6
  
  Details
- The impact of early mortality on the survival benefit of pediatric liver transplantation for primary liver malignancy
  
  Ali Abbasi (US) · 343-7
  
  Details

Therapeutic organ perfusion: From organ rescue to advanced clinical applications

11:00 AM – 12:00 PM Room C4.11 Abstract Session
Moderators: Dale Gardiner (GB), Sarah Scheuer (AU)
- First-in-Human Application of Extracorporeal Diseased Liver Perfusion Support (EDLPS) for Liver Failure
  
  Xiaoshun He (CN) · 344-1
  
  Details
- Development of the first pediatric DCD normothermic machine perfusion program: meeting the unmet need in pediatric liver transplantation
  
  Chun-Sing (Kevin) Huang (US) · 344-2
  
  Details
- The First 500 Kidneys Rescued Using Subnormothermic Acellular Perfusion (SNAP) at a Centralized Facility
  
  Giselle Guerra (US) · 344-3
  
  Details
- Subnormothermic machine perfusion for small intestinal ischemia reperfusion injury suppression and functional maintenance
  
  Satoshi Muto (JP) · 344-4
  
  Details
- Impact of Normothermic Perfusion Strategies on Early Liver Transplant Outcomes: A Comparison of On-Site versus Back-to-Base Strategies
  
  Santosh Nagaraju (US) · 344-5
  
  Details
- Targeting the TCF4-COL4A-CD44 axis ameliorates neutrophil-mediated inflammation during Ex Vivo liver normothermic machine perfusion
  
  Meiting Qin (CN) · 344-6
  
  Details
- Real-time assessment of regional glucose metabolism in human livers during normothermic machine perfusion using a portable microfluidic biosensing system
  
  Jitian He (CN) · 344-7
  
  Details
- Normothermic machine perfusion in high-acuity liver transplants with increased operative complexity: a comprehensive single-center experience
  
  Reghan Conrey (US) · 344-8
  
  Details

Lunch Break / Industry Symposia / Lunch with Experts & Mentors

Astellas Corporate Lunch Symposium on Strengthening the foundation: From tacrolimus consistency to durable graft outcomes

12:15 PM – 1:15 PM Room Parkside 1&2 Industry Symposium

Organized by

No lectures listed yet.

Lunch and Learn Roundtable

12:30 PM – 1:15 PM Room The Gallery Experts/Mentors
- Organ preservation, rejuvenation, and perfusion techniques
  
  Stefan Tullius (US)
- Living donor kidney transplantation & paired exchange
  
  Vivek Kute (IN)
- BK Guidelines
  
  Camille N. Kotton (US)
- "Organ Donation: From Death to Life". How to improve education about organ donation
  
  David Thomson (ZA)
- Grant Management
  
  Shaifali Sandal (CA)
- Transplant immunology & kidney injury
  
  Natasha Rogers (AU)
- Nursing Leadership in Transplant and Donation Systems
  
  Anne Floden (SE)
- Roundtable Mentor
  
  Nicole Isbel (AU)
- Roundtable Mentor
  
  Peter G. Stock (US)
- Roundtable Mentor
  
  Wenshi Jiang (CN)
- Roundtable Mentor
  
  Marcelo Cantarovich (CA)
- AMR in kidney transplant recipients
  
  William Mulley (AU)
- What strategies can effectively prevent unethical practices in donation and transplantation?
  
  Maria Amalia Matamoros (CR)
- DCD thoracic transplant
  
  Gregory I. Snell (AU)

SOTA, Thematic and Concurrent Sessions

Targeting immune cell metabolism to control alloimmunity

1:30 PM – 3:00 PM Room Cockle Bay 2 SOTA/Thematic Session
Moderators: Alexandra Sharland (AU), Mariam Alexander (US)
- How T cell metabolism regulates function and survival
  
  Carl Atkinson (US)
- Treg metabolism and the impact of metabolites on their function and disease progression
  
  Ling Lu (CN)
- Regulation of macrophage immunometabolism to drive immunity and inflammation
  
  Yohana Toner (NL)
- T cell landscapes following hematopoietic stem cell transplantation
  
  Antiopi Varelias (AU)

Redefining Surgical Excellence: Metrics, Equity, and Global Perspectives

1:30 PM – 3:00 PM Room C3.3 SOTA/Thematic Session
Moderators: Animesh Singla (AU), Peter G. Stock (US)
- Novel outcome metrics in surgery
  
  Pierre-Alain Clavien (CH)
- Driving quality improvement through global surgical registries
  
  Dimitri A. Raptis (SA)
- Ensuring diversity in the transplant surgery workforce
  
  Kendra Conzen (US)
- Beyond steatosis: The multisystem metabolic nature of fatty liver disease and its impact on surgical outcomes
  
  Nazia Selzner (CA)

Deceased Donation Research: Findings and Future Directions

1:30 PM – 3:00 PM Room C3.4-C3.5 SOTA/Thematic Session
Facilitator: Dominique Martin (AU)
- Donor intervention studies – ethical and practical challenges
  
  Dale Gardiner (GB)
- Deceased donor physiological management research
  
  Gary F. Marklin (US)
- Thoracic ex-situ machine perfusion research
  
  Sarah Scheuer (AU)
- Biobanks for research
  
  Claire Gordon (AU)
- Panel Discussion
  
  Discussion Period (AU)

Pluripotent stem cells and regenerative medicine: the future of transplantation?

1:30 PM – 3:00 PM Room C3.6 SOTA/Thematic Session
- Pluripotent stem cells: Where are we in building new lungs?
  
  Rhiannon Werder (AU)
- Tissue engineering and regenerative medicine: Perspectives on recent developments and directions
  
  Anthony Weiss (AU)
- Stem cell derived islets under abdominal anterior rectus sheath in a type 1 diabetes patient
  
  Shusen Wang (CN)

Biology and beyond: Multiple dimensions of transplantation

1:30 PM – 3:00 PM Room C4.1 SOTA/Thematic Session
Moderators: Yolanda Becker (US), Philip O'Connell (AU)
- Addressing gender disparity in access to pediatric kidney transplantation in India
  
  Kinnari Vala (IN)
- Social and cultural conflicts in uterine transplantation
  
  Limor Meoded Danon (IL)
- Impact of sex on cardiovascular outcomes after pediatric kidney transplantation
  
  Rizky Indrameikha Sugianto (DE)
- Intersection of sex/gender, and cancer after transplantation
  
  Brenda Maria Rosales (AU)

Life after transplant: Supporting movement, confidence, and long-term recovery across all levels of ability (WTGF)

1:30 PM – 3:00 PM Room C4.2 Concurrent
- The long-term transplant journey: What patients experience after discharge
  
  Liz Schick (CH)
- Movement when endurance is limited: Finding confidence through everyday activity
  
  Geoff Jessup (AU)
- From recovery to endurance sport: The transformative role of movement
  
  Kate Clark (AU)
- Clinical perspective: Encouraging safe physical activity after transplant
  
  Geoffrey McCaughan (AU)
- Panel discussion: Supporting all patients to move
  
  Discussion Period (AU)
  
  Details

Transplanting Against the Antibody Odds

1:30 PM – 3:00 PM Room C4.4 SOTA/Thematic Session
Moderators: Ankit Sharma (AU), Anne Halpin (CA)
- Overview of new HLA tools for measuring antibodies and rapid high resolution sequencing
  
  Sandra Tafulo (PT)
- Crossing DSA in lung transplant: Is necessity the mother of invention?
  
  Kieran Halloran (CA)
- Immune memory responses: Unmasking the hidden antibody potential
  
  Gonca E. Karahan (NL)
- Organ allocation strategies for HLA compatibility
  
  Philip Andrew Clayton (AU)

Emerging infectious diseases in transplant ID

1:30 PM – 3:00 PM Room C4.5 Concurrent
Moderator: Olivia Smibert (AU)
- Climate change and the changing epidemiology of transplant infections
  
  Wanessa T. Clemente (BR)
- On the move: Migration and the globalization of emerging pathogens
  
  Monica Slavin (AU)
- New outbreaks of old diseases: Measles and other re-emerging threats in transplantation
  
  Cameron Wolfe (US)
- Disease X and vaccine
  
  Deepali Kumar (CA)

Honouring voices, changing systems: Indigenous leadership in transplant equity

1:30 PM – 3:00 PM Room C4.6 SOTA/Thematic Session
Moderators: Jaquelyne Hughes (AU), Stephen McDonald (AU)
- Building an indigenous lived experience database in organ donation and transplantation
  
  Caroline Tait (CA)
- Ka whawhai tonu, ka haere ake: Fighting to advance transplant equity in Aotearoa New Zealand
  
  Curtis Walker (NZ)
- Wangkanthi purdita purruna naalitya - Talking kidney health for you Mob
  
  Kelli Owen (AU)
- Wangkanthi Purdita Purruna Naalitya - Talking Kidney Health for you Mob
  
  Stephen McDonald (AU)
- Panel Discussion and Q&A
  
  Discussion Period (AU)

Artificial intelligence (AI) in Transplant Education

1:30 PM – 3:00 PM Room C4.7 SOTA/Thematic Session
Moderator: Harry Robertson (AU)
- From concept to classroom: How to start using AI in transplant education?
  
  Susu Zughaier (QA)
- Mixed reality technology in organ transplantation
  
  Alfred Kow (SG)
- AI in Transplantation: AI capabilities, applications and responsible use
  
  Bill Simpson-Young (AU)
- Panel Discussion
  
  Discussion Period (AU)

Global collaboration in organ transplantation: Advancing ethical access, innovation, and sustainability

1:30 PM – 3:00 PM Room C4.8 Concurrent
Moderators: Rajdeep Das (US), Marcelo Cantarovich (CA)
- Global organ sharing & research collaborations
  
  Axel Rahmel (DE)
- Economics of transplantation
  
  Vasanthi Ramesh (IN)
- Capacity building in low-resource settings
  
  Medhat Askar (QA)
- Ethical, cultural & patient-centered considerations
  
  Jeremy Chapman (AU)

Transplant Oncology: Peering Over the Horizon

1:30 PM – 3:00 PM Room C4.9 SOTA/Thematic Session
Moderators: Kwang Woong Lee (KR), Mohamed Rela (IN)
- Liver transplantation for unresectable hilar cholangiocarcinoma: Who truly benefits?
  
  Julie Heimbach (US)
- Neuroendocrine tumours and liver transplantation: Time to move beyond traditional boundaries?
  
  Takashi Ito (JP)
- Intrahepatic cholangiocarcinoma and liver transplantation: Pushing the limits of what’s surgically and biologically possible
  
  Sudha Kodali (US)
- Liver transplantation for hepatoblastoma: Does biology drive the decision to transplant?
  
  Mohamed Rela (IN)
- Liver transplantation for non-hepatoblastoma paediatric tumours: LT as a curative tool?
  
  Seisuke Sakamoto (JP)

ISOT: Redefining organ transplantation in resource-limited settings: Access, affordability, and global leadership from India - Part 1

1:30 PM – 3:05 PM Room C4.10 Concurrent
Moderators: Ravi Mohanka (IN), Swarnalatha Guditi (IN), Divyesh Engineer (IN), Amit Pasari (IN), Abi Abraham Mookanottle (IN), Amol Bhawane (IN), Sreebhushan Raju (IN), Manish Balwani (IN), Feroz Aziz (IN)
- Organ transplantation in India: Current status and emerging opportunities
  
  Sanjay Kolte (IN)
- Government reforms to increase access to organ transplantation: Policy innovations and outcomes
  
  Anil Kumar (IN)
- Optimizing transplant outcomes through cost-effective immunological evaluation in LMICs
  
  Manoj Gumber (IN)
- Regional success models in deceased donation: Pathways to national self-sufficiency in organ transplantation
  
  Subho Banerjee (IN)
- Improving access to living donor kidney transplantation through kidney exchange programmes
  
  Vivek Kute (IN)

Obesity Management in Transplantation: Current Evidence and Practical Approaches

1:30 PM – 3:00 PM Room C4.11 SOTA/Thematic Session
Moderators: Dorry Segev (US), Marina Berenguer (ES)
- Latest evidence on GLP-1s in transplantation
  
  Babak Orandi (US)
- Managing obesity without GLP-1s: Alternative strategies
  
  Amanda Velazquez (US)
- Bariatric surgery in transplantation: Opportunities and challenges
  
  Shashank R. Joshi (IN)
- Facilitating weight loss in individuals with frailty and sarcopenia
  
  Astrid Ruiz-Margáin (MX)

Coffee Break / Exhibits and Poster Viewing

Coffee Break

3:00 PM – 3:30 PM Room Hall 1-2 Coffee Break

No lectures listed yet.

TSANZ President Session / Afternoon Abstract and Concurrent Sessions

TSANZ President's Prize Awards

3:30 PM – 6:00 PM Room Cockle Bay 1 Plenary Session
- Validation of a novel non-invasive method based on evaluating urinary exfoliated proximal tubule kidney cell multispectral autofluorescence to differentiate between causes of kidney transplant complications
  
  Henry H L Wu (AU) · 380-1
  
  Details
- Developing a prediction model for the time from withdrawal of cardiorespiratory support to death in controlled donation after circulatory determination of death donors
  
  Ryan Gately (AU) · 380-2
  
  Details
- Immune invisible kidney allografts: eliminating MHC II expression with cytosine base editing to prevent antibody-mediated kidney transplant rejection
  
  Ailish Barry (AU) · 380-3
  
  Details
- Impact of Repeat HLA Mismatches on Graft Outcomes in Kidney Transplantation in Australia
  
  Henry Guo (AU) · 380-4
  
  Details
- A single-cell imaging atlas of the peripheral immune system in kidney transplant recipients
  
  Griffith Perkins (AU) · 380-5
  
  Details
- Fatherhood and Kidney Replacement Therapy: Analysis of linked ANZDATA Registry and perinatal data
  
  Su Jen Chua (AU) · 380-6
  
  Details
- Peripheral T cell transcriptomic profile is altered in non-human primate kidney transplant recipients treated with ECDI-fixed donor B cell infusions
  
  Matthew Tunbridge (AU) · 380-7
  
  Details
- Who gets a kidney transplant? International differences in kidney transplant waitlisting, transplantation and mortality in the US, UK and Australia
  
  Lachlan McMichael (AU) · 380-8
  
  Details

Organ preservation 2

3:30 PM – 4:30 PM Room Cockle Bay 2 Abstract Session
Moderator: Henry Pleass (AU)
- Metabolic reprogramming by modulation of histone lactylation improves liver graft preservation and function
  
  Xiao Tang (CN) · 381-1
  
  Details
- Xenon-enhanced gaseous perfusion under high pressure: a scalable strategy for heart preservation
  
  Alexander Ponomarev (US) · 381-2
  
  Details
- Towards next-generation organ preservation - molecular insights from long-term normothermic machine perfusion of human livers for up to 7 weeks
  
  Anita Niu (AU) · 381-3
  
  Details
- Histone acetylation improves liver graft function via ADCY3-cAMP-mediated metabolic reprogramming
  
  Zhoucheng Wang (CN) · 381-4
  
  Details
- The First Demonstration of Kidney Allo- and Autotransplantation After 72 Hours of Simple, Cryoprotectant-Free Subzero Preservation, with Pilot Extension to 96–120 Hours
  
  Anthony Consiglio (US) · 381-5
  
  Details
- Hypothermic Oxygenated or Normothermic Kidney Perfusion – Which Perfusion Technique Protects Mitochondria Best?
  
  Keyue Sun (US) · 381-6
  
  Details
- Inhibiting ferroptosis alleviates cold-induced injury in porcine lung tissue slices
  
  Fernanda Yamamoto Ricardo da Silva (CA) · 381-7
  
  Details

Biomarkers, pharmacokinetics and kidney allograft outcomes

3:30 PM – 4:30 PM Room C3.3 Abstract Session
Moderator: Toby Coates (AU)
- Autonomous AI pathology and spatial transcriptomics reveal inflammatory niches driving i-IFTA in kidney allografts
  
  Harry Robertson (AU) · 382-1
  
  Details
- Evaluating urinary volatile organic compounds as a novel metabolomic biomarker to differentiate between acute tubular necrosis and acute graft rejection following kidney transplantation
  
  Henry H L Wu (AU) · 382-2
  
  Details
- Combined genomic transplant and pharmacogenomic risk assessment for pediatric renal patients using Oxford Nanopore Adaptive Sampling
  
  Karen Sherwood (CA) · 382-3
  
  Details
- A Multicenter Randomized Controlled Trial Of Urine CXCL10 Monitoring Post-Kidney Transplant
  
  Julie Ho (CA) · 382-4
  
  Details
- Consistently Low Donor-derived Cell-Free DNA Identifies Allograft Stability In Kidney Transplant Recipients
  
  Hossein (Hoss) Tabriziani (US) · 382-6
  
  Details
- Biopsy-proven recurrent IgA nephropathy after kidney transplantation in a multi-ethnic Southeast Asian cohort
  
  Zi Yun Chang (SG) · 382-7
  
  Details

Immunoregulation: Cell signalling 2

3:30 PM – 4:30 PM Room C3.4-C3.5 Abstract Session
- Investigation of immune responses to SLA-derived antigens presented on HLA class II
  
  Ken Kawada (JP) · 383-1
  
  Details
- Mechanism of GSTM3-mediated glutathionylated modification of FKBP5 regulating autophagy in Steatotic liver ischemia-reperfusion injury
  
  Wen Hou (CN) · 383-3
  
  Details
- Spatial Transcriptome Analysis Identifies Endothelial HLA-F as a Prognostic Marker in Kidney Antibody-Mediated Rejection
  
  Toshihito Hirai (JP) · 383-4
  
  Details
- Reversing TCMR through inhibition of innate immune allorecognition
  
  Geoffrey Camirand (US) · 383-6
  
  Details
- The “inflamed self” – perturbations of the murine immunopeptidome during ischaemia-reperfusion injury and transplantation
  
  Alexandra Hill (AU) · 383-7
  
  Details
- PHLDA1 as a Key Regulator in Renal Ischemia-Reperfusion Injury: Implications for Fatty Acid Metabolism and Ferroptosis
  
  Zejiaxin Niu (CN) · 383-8
  
  Details
- Role of CXCL10 in Mediating T-Cell Infiltration and Phenotypic Remodeling in Renal Ischemia-Reperfusion Injury in Mice
  
  Tian Wei (CN) · 383-9
  
  Details

Precision immunosuppression and therapeutic optimization in transplantation: Kidney-centered advances across solid organ care

3:30 PM – 4:30 PM Room C3.6 Abstract Session
Moderators: Shyam Bihari Bansal (IN), Yolanda Becker (US)
- Edge-AI-enabled Aptamer Impedance Biosensor for Real-time Point-of-care Tacrolimus Therapeutic Drug Monitoring
  
  Juhan Lee (KR) · 384-1
  
  Details
- A clinical study on the reduction of donor lymphocyte chimerism rate in recipient tissues after liver transplantation by extracorporeal perfusion of anti-thymocyte globulin via portal vein
  
  Jinzhen Cai (CN) · 384-2
  
  Details
- 10-year analysis of low-Tacrolimus/Everolimus versus regular triple therapy for elderly recipients. The nEVERold trial
  
  Elias David-Neto (BR) · 384-3
  
  Details
- Proton-pump inhibitors: an opportunity for deprescribing in the solid organ transplant population
  
  Anna Posthumus (NL) · 384-4
  
  Details
- Building model-informed precision dosing platforms for tacrolimus in lung, heart and bone marrow transplantation
  
  Dirk Kuypers (BE) · 384-5
  
  Details
- An algorithm-driven predictive strategy for personalized tacrolimus dosing in kidney transplant recipients
  
  Guodong Chen (CN) · 384-6
  
  Details
- Balanced Electrolyte Solutions in Kidney Transplantation: CARI Guidelines Evidence-Based Recommendations for Improved Outcomes:
  
  David Tunnicliffe (AU) · 384-7
  
  Details
- Efficacy and safety of low dose trimethoprim-sulfamethoxazole for pneumocystis jirovecii pneumonia in kidney transplant recipients: a retrospective cohort study
  
  Xuqin Jiang (CN) · 384-8
  
  Details

Overcoming immune barriers in xenotransplantation: From innate recognition to gene-edited graft compatibility

3:30 PM – 5:00 PM Room C4.1 Abstract Session
Moderator: Peter Cowan (AU)
- Loss of Neu5Gc in donor erythrocytes unlocks species-specific innate checkpoints governing macrophage recognition in xenotransplantation
  
  Wang Yi (CN) · 385-1
  
  Details
- Normothermic Machine Perfusion of Human Kidneys Using Triple-Knockout Pig Red Blood Cells
  
  Yizhong Tu (CN) · 385-2
  
  Details
- Human Thrombomodulin Improves Early Coagulopathy, but Innate Immune–Driven Injury Limits Survival in Pig-to-NHP Liver Xenotransplantation
  
  Zhongqiang Zhang (CN) · 385-3
  
  Details
- First Large-Cohort Study Profiling the Baseline Immunological Status for Xenotransplantation in Liver Transplant Candidates: Implications for Safe Bridging from Gene-Edited Pigs
  
  Liaoran Wang (CN) · 385-4
  
  Details
- Antibody responses against swine leukocyte antigens contribute to early rejection after pig-to-monkey kidney xenotransplantation
  
  hao feng (CN) · 385-5
  
  Details
- Preformed and De Novo Xenoreactive IgM Antibodies Contribute to Early Xenograft Loss in Pig-to-Monkey Kidney Xenotransplantation
  
  Man Zhang (CN) · 385-6
  
  Details
- Sequential Allotransplantation After Failure of Pig-to-Rhesus monkey Kidney Xenotransplantation: A Case Report
  
  Man Zhang (CN) · 385-7
  
  Details
- Flow cytometry immune profiling provides early detection of rejection of islet xenotransplants
  
  Thanh Le (AU) · 385-8
  
  Details
- HLA E CD94 NKG2A pathway confers superior NK cell resistance compared to extensive multitransgenic modifications in porcine endothelial cells
  
  Jonathan Schulz (DE) · 385-9
  
  Details
- Endothelial PlexinB2 suppresses human neutrophil activation in a humanized xenotransplantation model
  
  Soichi Matsumura (JP) · 385-10
  
  Details

Imaging and biomarkers to assess kidney allograft dysfunction

3:30 PM – 4:30 PM Room C4.4 Abstract Session
Moderators: Samuel Neeling (AU), Terence Kee (SG)
- Integrated immune profiling distinguishes polyomavirus nephropathy from rejection phenotypes in kidney allografts
  
  Binnaz Handan Ozdemir (TR) · 387-1
  
  Details
- Donor-derived Cell-free DNA As A Prognostic Biomarker In Biopsy-negative Kidney-transplant Recipients
  
  Hossein (Hoss) Tabriziani (US) · 387-2
  
  Details
- Ultrasound assessment of the effect of patient position and body shape on peri-operative renal transplant cortical resistive indices and perfusion
  
  Charles FISHER (AU) · 387-3
  
  Details
- Real world experience of using the molecular microscope diagnostic system MMDx in the management of allograft dysfunction in a multiethnic asian kidney transplant recipient population
  
  Terence Kee (SG) · 387-4
  
  Details
- The influence of ultrasound guidance quality on kidney transplant biopsy outcomes: A systematic review and meta-analysis
  
  David Su (AU) · 387-5
  
  Details
- Genetic association in patients with chronic kidney disease of undetermined etiology: An observational study
  
  tarun kumar (IN) · 387-6
  
  Details
- Donor-derived cell-free DNA during delayed graft function: Insights from the KOAR registry
  
  Giselle Guerra (US) · 387-7
  
  Details
- Contrast-Enhanced Ultrasound in differentiating Acute Rejection from Acute Tubular Necrosis based on biopsy results in Renal Allograft Dysfunction: a Prospective Study
  
  Sai Aishwarya Valluri (IN) · 387-8
  
  Details

Optimization strategies in living donor liver transplantation

3:30 PM – 4:30 PM Room C4.5 Abstract Session
Moderator: Dimitri A. Raptis (SA)
- The 2023-2025 Global Report Of The International Living Donor Liver Transplant Registry (LDLTgroup.org
  
  Enrico Prosperi (IT) · 388-1
  
  Details
- Graft-to-Recipient Weight Ratio, Graft Inflow Modulation, and Small-for-Size Syndrome: A Multicenter Prospective Study from the International Living Donor Liver Transplant Registry (LDLTregistry.org)
  
  Enrico Prosperi (IT) · 388-2
  
  Details
- Risk-Benefit Benchmarking in Liver Transplantation for Hepatocellular Carcinoma: a cohort study based on the CLTR and UNOS database
  
  Fengqiang Gao (CN) · 388-3
  
  Details
- Impact of Preoperative Weight Reduction on Donor and Recipient Outcomes in Living Liver Transplantation
  
  Jaehyun Kwon (KR) · 388-4
  
  Details
- THE OUTCOMES OF RE-LIVER TRANSPLANTATION: A SINGLE-CENTER EXPERIENCE
  
  Kyung Chul YOON (KR) · 388-5
  
  Details
- Outcomes of highly urgent ABO-incompatible living donor liver transplantation in national databases
  
  JAE-WON JOH (KR) · 388-6
  
  Details
- Robotic donor hepatectomy is associated with superior long-term outcomes compared to laparoscopic or open: A single-center prospective registry study of 2,102 cases
  
  Dieter Broering (SA) · 388-7
  
  Details
- Infrared Thermal Imaging Enables Real-Time Mapping of Perfusion Heterogeneity and Predicts Functional Recovery in Liver Grafts During Machine Perfusion: A First-in-Field Ex Vivo Study
  
  Nabeel M (IN) · 388-8
  
  Details
- Longitudinal body composition changes following pre-donation defatting programs in living liver donors: a CT-based analysis
  
  Francesca Albanesi (IT) · 388-9
  
  Details

Engineering immune compatibility in transplantation: Gene editing, cell therapy, and regenerative strategies

3:30 PM – 4:30 PM Room C4.6 Abstract Session
- Construction and properties characterization of a novel ceramic membrane-based artificial kidney hemofilter
  
  Luoyi Chen (CN) · 389-1
  
  Details
- Endometrial regenerative cells-derived exosome hydrolyzes 2′3′-cGAMP to inhibit cGAS-STING pathway in alleviating acute allograft rejection via surface enzyme ENPP1
  
  Bo Shao (CN) · 389-2
  
  Details
- Immortalized Hypoimmune Human Mesenchymal Stem Cells for Immunomodulation and Wound Healing
  
  Katrin Hacke (US) · 389-3
  
  Details
- CRISPRa-Mediated CTRP9 Gene Overexpression Prevents Graft Loss After Islet Transplantation
  
  Xingshi Gu (CN) · 389-5
  
  Details
- Preventive Effect of Human-Induced Renal Progenitor Cells on Delayed Graft Function After Kidney Transplantation in Rats
  
  Haiwei Chen (CN) · 389-6
  
  Details
- Transplant patient-derived explanted livers serve as an excellent source for developing disease-specific ex vivo microenvironment for personalized liver organoid engineering
  
  Tanveer Mir (SA) · 389-8
  
  Details

Solving immune problems for the life of the allograft

3:30 PM – 4:30 PM Room C4.7 Concurrent
Moderators: Xunrong Luo (US), Kieran Halloran (CA)
- Single cell transcriptomic profiling focusing on donor reactive T cells of operational tolerance recipient after liver transplantation
  
  NAOKI TANIMINE (JP) · 390-1
  
  Details
- 10-year outcomes for autologous polyclonal ex-vivo-expanded Treg cellular therapy in renal transplantation (ONE study UK Treg Trial)
  
  Charlotte Yates (GB) · 390-2
  
  Details
- Single cell spatial technologies in kidney allograft pathology- inflammation, fibrosis and beyond
  
  Mariam Alexander (US)
- Direct and indirect allorecognition – more alike than we thought?
  
  Gavin Pettigrew (GB)

Precision virology in transplantation: Immunity, diagnostics, and targeted therapies

3:30 PM – 4:45 PM Room C4.8 Abstract Session
Moderators: Matthew Roberts (AU), Tina Marinelli (AU)
- The post-transplant lymphoproliferative disorders metagenomic shotgun microbial sequencing (PTLD-MSMS) study: clinical insights from the full cohort
  
  Vikas Dharnidharka (US) · 391-1
  
  Details
- Phase I Clinical Evaluation of Allogeneic Virus-Specific T Cell Therapy in Solid Organ Transplant Recipients with Refractory Viral Infections
  
  Rajiv Khanna (AU) · 391-2
  
  Details
- Measles immunity before and after solid organ transplantation: evidence for preserved protective neutralizing antibody
  
  Camille N. Kotton (US) · 391-3
  
  Details
- Proximal Tubule-Derived SPP1 Activates Proteotoxic Stress Response and CD8⁺ T Cell Exhaustion in BK Polyomavirus Nephropathy
  
  Yingzhen He (CN) · 391-4
  
  Details
- Virologic clearance with maribavir by baseline cytomegalovirus DNAemia in solid organ transplant recipients: A post hoc analysis of phase 2 and 3 trials
  
  Deepali Kumar (CA) · 391-5
  
  Details
- Comparing the post-omicron transplant impact of SARS-COV2 and other respiratory viral infections
  
  Beatrice Sim (AU) · 391-6
  
  Details
- Real-world effectiveness and safety of maribavir in solid organ transplant recipients with refractory/resistant cytomegalovirus or intolerance to anti-cytomegalovirus drugs: Interim results from the ARISE study
  
  Nassim Kamar (FR) · 391-7
  
  Details
- Real-world CMV hyperimmunoglobulin prophylaxis in heart and lung transplantation: one-year interim results from a prospective multicenter study
  
  Markus Barten (DE) · 391-8
  
  Details
- Real world efficacy of maribavir when used as pre-emptive therapy for cytomegalovirus reactivation in alloHCT patients who are intolerant, refractory or resistant
  
  Violet Zhu (AU) · 391-9
  
  Details
- Donor-Derived Severe Dengue in a Kidney Transplant Recipient Uncovered Pathogenic Neutrophil Inflammation and Protective CD14+ Monocyte Antiviral Programs
  
  YING SU (CN) · 391-10
  
  Details

TTS-ISN: Pregnancy in renal transplant recipients - Outcomes, barriers, and clinical management

3:30 PM – 4:30 PM Room C4.9 Concurrent

in collaboration with:
Moderator: Curie Ahn (KR)
- The pregnancy after renal transplantation OUTcomes registry (PARTOUT) in the Netherlands with granular data
  
  Margriet de Jong (NL)
- Assessing risk and overcoming barriers in pregnancy after kidney transplantation
  
  Shilpanjali Jesudason (AU)
- Supporting pregnancy in transplant recipients: current best practice care and controversies
  
  Sumoyee Basu (GB)

Integrated machine perfusion strategies for DCD organ optimization and transplant outcomes

3:30 PM – 4:30 PM Room C4.11 Abstract Session
Moderator: John Whitlam (AU)
- Sequential NRP and hypothermic versus normothermic ex-situ perfusion in extended criteria DCD liver transplantation
  
  Daniele Pezzati (IT) · 393-1
  
  Details
- A pragmatic alternative to commercial perfusion devices: routine liver machine perfusion using a heart–lung machine
  
  Mikhail Boldyrev (RU) · 393-2
  
  Details
- Early outcomes after sequential hypothermic, controlled oxygenated rewarming and normothermic machine perfusion combined with TPA thrombolysis for DCD liver graft optimisation
  
  Adam Philipoff (AU) · 393-3
  
  Details
- Automated and continuous hypothermic to normothermic machine perfusion minimises injury in porcine livers and restores function in high-risk human livers
  
  Hatem Sadik (GB) · 393-4
  
  Details
- Routine use of the modified HTK-based perfusate for hypothermic oxygenated perfusion enables safe transplantation of suboptimal liver allografts: a single center experience
  
  Stepan Zubenko (RU) · 393-5
  
  Details
- Impact of Hypothermic Oxygenated Machine Perfusion on Early Outcomes in Kidney Transplantation from Uncontrolled Donors
  
  Elmira Tenchurina (RU) · 393-6
  
  Details
- Factors Associated with Prolonged Case Time in Deceased Organ Donation
  
  Carolyn Sidoti (US) · 393-7
  
  Details
- Combined liver-kidney normothermic machine perfusion with bioartificial liver support for 48-hour ex vivo recovery of donation after circulatory death organs
  
  Zibiao Zhong (CN) · 393-8
  
  Details
- Liver and combined liver-pancreas grafts from pediatric DCD donors utilizing normothermic regional perfusion – age or size should not limit the practice
  
  David Walls (US) · 393-9
  
  Details

ISOT: Redefining organ transplantation in resource-limited settings: Access, affordability, and global leadership from India - Part 2

3:35 PM – 6:10 PM Room C4.10 Concurrent
Moderators: Shruti Tapiawala (IN), Gireesh MS (IN), Mohan Patel (IN), Raj Kanwar Yadav (IN), Dhananjai Agarwal (IN), Dhananjaya KL (IN), Pranjal Kashiv (IN), Ashish Sharma (IN), Narayan Prasad (IN), Arpita Ray Chaudhury (IN), Vikas Jain (IN), Sourabh Sharma (IN), Pankaj Shah (IN)
- Making ABO-incompatible transplantation affordable for low- and middle-income countries: Scalable cost-reduction strategies
  
  Deepak S. Ray (IN)
- HLA desensitization in transplantation in LMIC: Balancing access, cost, and clinical outcomes
  
  Umapati Hegde (IN)
- Integrating cell-free DNA surveillance into cost-effective organ transplantation pathways in LMIC settings
  
  Pratik Das (IN)
- Gender disparity in organ transplantation: Insights and lessons from LMIC
  
  Khushboo Saxena (IN)
- Pioneering surgical techniques in transplantation: The global south contribution to global practice
  
  Pranjal Modi (IN)
- ISOT position statements for increasing access to transplantation
  
  Jigar Shrimali (IN)

Workshop Sessions / Industry Symposium / Poster Sessions

Multidisciplinary: Leveraging shared infrastructure for hematopoietic stem cell and solid organ transplantation

4:45 PM – 6:00 PM Room C4.6 Concurrent
Moderators: Medhat Askar (QA), Marcelo Cantarovich (CA)
- The challenge of siloed program building vs. opportunities of integration
  
  Markus Selzner (CA)
- Immunologic bridge
  
  Rajdeep Das (US)
- One pathogen, two populations
  
  Monica Slavin (AU)
- Beyond the graft
  
  Teun van Gelder (NL)
- Panel discussion on global perspectives on integration and innovation
  
  Discussion Period (AU)

Approaching and navigating difficult conversations with transplant patients

4:45 PM – 6:00 PM Room C4.7 Concurrent
Moderator: David Thomson (ZA)
- Conversations around kidney transplant evaluation: Who and how to communicate non-eligibility for transplant
  
  Rhiannon Reed (US)
- Palliative care post-transplant: Throughout patient journey and symptom management
  
  Kathryn Ducharlet (AU)
- Navigating through organ failure to transplant: Liver transplant
  
  Suk Kyun Hong (KR)
- Navigating conversations on cardiac mechanical support therapy to heart transplant
  
  Shunichi Nakagawa (US)

Poster Session 2

4:45 PM – 6:00 PM Room Hall 1-2 Posters

Open session view

No lectures listed yet.

General topics

4:45 PM – 6:00 PM Room Hall 1-2 Posters
- A case of false four DRB1 alleles test from a patient with liver cirrhosis
  
  hyewon park (KR) · P2-425
  
  Details
- Research Gaps and Emerging Priorities in Liver Transplantation: A Systematic Landscape Analysis of Clinical Trials and Published Literature, 2000–2025
  
  Jeong-Moo Lee (KR) · P2-426
  
  Details
- Survey of ISODP 2025 Attendees on Donor Family Support Following Deceased Organ Donation
  
  Miho Shingu (JP) · P2-427
  
  Details
- Analysis of Family Refusal Reasons for Brain-Dead Organ Donation in Korea and International Comparison
  
  Myoungkyun Seo (KR) · P2-428
  
  Details

KDIGO Sponsored Symposium

5:00 PM – 6:00 PM Room C3.3 Industry Symposium

This program is supported by an independent educational grant from Veloxis, an Asahi Kasei company

No lectures listed yet.

Networking Events

TSANZ Networking Event

6:00 PM – 7:00 PM Room Cockle Bay 1 Networking Event

Sponsored by

No lectures listed yet.

Mentee-Menor Networking Events

6:00 PM – 7:00 PM Room C4.4 Networking Event

No lectures listed yet.

Congress Networking Event (ICC)

7:00 PM – 10:00 PM Room ICC Grand Ballroom Networking Event

No lectures listed yet.